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Abstract
Purpose—Conduct a randomized controlled trial of educational interventions to improve 
performance of screening mammography interpretation.
Materials and Methods—We randomly assigned physicians who interpret mammography to 
one of three groups: (1) self-paced DVD; (2) live, expert-led educational session; or (3) control. 
The DVD and live interventions used mammography cases of varying difficulty and associated 
teaching points. Interpretive performance was compared using a pre-/post-test design. Sensitivity, 
specificity, and positive predictive value (PPV) were calculated relative to two outcomes: cancer 
status and consensus of three experts about recall, and each were compared using logistic 
regression adjusting for pre-test performance.
Results—102 radiologists completed all aspects of the trial. After adjustment for pre-
intervention performance, the odds of improved sensitivity for correctly identifying a lesion 
relative to expert recall were 1.34 times higher for DVD participants than controls (95% 
confidence interval [CI]: 1.00, 1.81; P=0.050). The odds of improved PPV for correctly 
identifying a lesion relative to both expert recall (odds ratio [OR]=1.94, 95% CI: 1.24, 3.05; 
P=0.004) and cancer status (OR=1.81, 95% CI: 1.01, 3.23; P=0.045) were significantly improved 
for DVD participants compared to controls with no significant change in specificity. For the live-
intervention group, specificity was significantly lower than the control group (OR relative to 
expert recall=0.80; 95% CI: 0.64, 1.00; P=0.048; OR relative to cancer=0.79; 95% CI: 0.65, 0.95; 
P=0.015).
Conclusion—In this randomized controlled trial, the DVD educational intervention resulted in a 
significant improvement in mammography interpretive screening performance on a test-set, which 
could translate into improved clinical interpretative performance.
Introduction
In the United States, interpretive performance of screening mammography shows significant 
variability (1,2). While numerous studies have sought to understand the sources of 
variability, such as interpretive volume, malpractice concerns, and other radiologist 
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characteristics (2-9), only a few have focused on practical approaches to improve 
interpretive performance (10-16). In two studies with multi-component interventions to 
enhance radiologists’ interpretive performance, the components that contributed most to the 
observed effects could not be determined (10,14).
The Mammography Quality Standards Act (MQSA) requires physicians who interpret 
mammography to obtain at least 15 hours of category 1 Continuing Medical Education 
(CME) units in mammography every 36 months to maintain their qualifications (1). Also 
under MQSA, a lead interpreting physician is required to review mammography audit data 
and provide feedback on performance. However, the persistence of significant variability in 
interpretive performance has led to attempts to go beyond CME to improve interpretive 
skills. An IOM report suggested modifying the MQSA CME requirements to specifically 
focus on skills assessment using test sets with a mix of normal and abnormal findings. This 
assessment method would compare the performance of interpreting physicians with their 
peers to provide them with feedback on their interpretive skills and identify areas for 
improvement (17).
We conducted a randomized controlled trial of two educational interventions designed to 
improve performance of screening mammography interpretation. We tested the hypotheses 
that: (1) test sets of mammographic images developed with teaching points would increase 
physicians’ ability to identify screening mammography findings that required recall for 
further work-up, (2) that mode of delivering these interventions (self-paced DVD versus live 
instructional program) would have different effects, and (3) that this increased ability would 
result in improved interpretive performance.
Materials and Methods
We conducted a three-arm, block-randomized, controlled trial to evaluate two interventions 
to improve screening mammography interpretative performance. A pre-/post-intervention 
test set design was used to evaluate the impact of a self-paced DVD and a live expert-led 
seminar compared to a control group. Both the live intervention and the self-paced DVD 
included 40 cases, 18 of which were biopsy confirmed cancers.
Study population
In 2009–2010, 300 radiologists who interpreted mammograms at a facility contributing to a 
Breast Cancer Surveillance Consortium (BCSC) registry between 2005 and 2006 were 
invited to participate. We also invited 103 non-BCSC radiologists from Oregon, 
Washington, North Carolina, San Francisco, and New Mexico. Institutional Review Board 
approval was obtained by each registry and the Statistical Coordinating Center (SCC) that 
performed the analysis for all study activities, including active consent to enroll radiologists 
and perform analytic studies. All registries and the SCC followed Health Insurance 
Portability and Accountability Act-compliant procedures to obtain mammography films and 
patient information, and received a Federal Certificate of Confidentiality and other 
protections for the study participants and the identities of women, physicians, and facilities 
related to the films we used (18).
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We randomized the 119 radiologists who completed a pre-intervention test set into one of 
the three groups (Figure 1). Because we only offered the live intervention once on the west 
coast and once on the east coast, it was not possible for some radiologists assigned to the 
live intervention to attend. If a radiologist provided a legitimate reason for not attending the 
live seminar, we re-randomized him or her to either the DVD or control group, making these 
groups larger than the live intervention group. Additionally, one individual who was 
originally randomized to the DVD group was inadvertently invited to join one of the live 
seminars, and accepted, so we retained this individual in the live intervention group.
Pre-intervention and post-intervention test sets
The test sets used to evaluate performance are described elsewhere (6). Briefly, a random 
sample of original screening mammography films from registries of the National Cancer 
Institute-funded BCSC (19) were digitized by the American College of Radiology (ACR) to 
create four pre-intervention test sets and one post-intervention test set. Three expert 
mammographers (BM,,EAS, LB) with extensive breast imaging experience of 32-36 years 
reviewed all digitized cases to determine which should be recalled for further work-up. The 
pre-intervention test sets consisted of four test sets, each included 109 screening 
mammograms, that were created as part of a larger study designed to test whether disease 
prevalence or case difficulty in a test set changes the association between test set 
performance and clinical performance (20). Our process for developing the test sets, 
interventions and feedback was very similar to the PERFORMS project in the United 
Kingdom (15,16). Before performance evaluation with the pre-intervention test set, 
participants took a brief survey about their training and experience. Radiologists from all 
three groups (DVD, Live Seminar and control) who completed one or more component (pre-
intervention/post-intervention test set, an intervention) received an individualized audit 
feedback report after each component. These reports provided tabular and graphic results of 
their performance compared with the experts and with the aggregated performance of 
participants who interpreted the same test set or the same intervention.
Computer Requirements
Minimum mandatory computer requirements included:
• Processor: Pentium 4 with 1GHz or higher preferred (also newer processors such 
as Intel Core Duo or AMD×2)
• RAM: 1GB
• Display: Minimum 17″ (larger is better) capable of displaying 1280×1024 or 
higher in 32-bit color. A laptop needed to have a 15.4″ or larger screen capable of 
displaying 1440 ×900 or higher
• DVD-ROM drive
• Hard Drive: At least 40GB
• Internet access from the computer on which the test DVD was read..
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We loaned laptops to radiologists who did not have computers that met these requirements.
Intervention Development
The teaching set was generated based on pre-intervention test set performance. We 
determined the types of mammographic findings that were commonly missed and 
misinterpreted and chose 40 cases, none of which appeared on the subsequent post-
intervention test set, with 18 cancers visible on the mammograms, 6 non-cancers that the 
experts recalled for sufficiently high probability of cancer, and 16 non-cancers not recalled 
by the experts. Among the 18 cancers, the expert radiologist panel categorized films by their 
most serious findings, identifying 3 with masses, 4 with calcifications, 7 with asymmetry, 
and 4 with architectural distortion. Experts considered 8 of the cancers to be of intermediate 
difficulty and 6 as subtle. Four cases, borrowed from the Mammography Interpretive Skills 
Assessment (MISA) test set (21,22), were not assessed by experts for difficulty. Fifteen of 
the 18 cancers were interpreted clinically as true positives, and three were false negatives. 
Each case provided current craniocaudal (CC) and mediolateral-oblique (MLO) views and 
CC and MLO views from one prior comparison examination. Our expert panel wrote a 
teaching point for each case. All teaching points had a final review by a single expert 
radiologist.
Two cases in the pre-intervention test sets had more than one lesion within a breast, but 
cases were reviewed and experts agreed on which lesion was the most significant. 
Instructions provided to participants directed them to choose the most significant lesion. If 
there was a mass with adjacent microcalcifications, for example, the region of interest was 
wide and clicking within any of the area would give the radiologist credit for the finding. 
The test-takers could not mark multiple locations.
Self-paced DVD—A DVD was developed using the teaching set that allowed radiologists 
to learn the intervention content at their convenience. The DVD used the same 40 cases as 
the live session and 21 additional cases, including one additional MISA case, for radiologists 
who wanted more practice. Participants checked a box for either a positive assessment 
(Breast Imaging Reporting and Data System [BI-RADS] categories 0, 4, 5) or a negative 
assessment (BI-RADS 1, 2). For positive assessments, participants marked the location of 
the most important finding. After submitting an answer, the participant was immediately 
told if the response was correct. Next, the examination was shown again, with any important 
findings marked. A teaching point was displayed that explained the reason to recall or not 
recall the case, with explanations of any findings or the information that the case had no 
significant finding. Additional imaging was included with the teaching point when available 
(see Figure 2). Our software was designed by the ACR based on their MISA program with 
modifications as specified (21).
Live expert-led seminar—The live seminar was a one-day, eight-hour course taught by 
two experts and held in San Francisco, CA (LB, EAS) and Hanover, NH (BM, EAS). 
Participants reviewed teaching set cases on individual workstations in a classroom of 
networked computers, answering the same questions as on the DVD. When the entire group 
was finished with a case, data were aggregated and shared with the entire class by projecting 
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de-identified results on an overhead screen. Participants could compare their interpretations 
on their own computers to the group.
The expert instructor reviewed the correct interpretation and described the teaching points, 
commented on participant interpretations, and responded to questions. For example, if a 
large proportion recalled a benign finding (false-positive), the instructor discussed why 
experts would or would not recall the case.
Two months after all participants had completed the live interventions or the self-paced 
DVD, each participant was given audit feedback showing individual performance compared 
with the aggregated performance of participants in the same intervention group, relative to 
both expert recall and cancer status.
Among participants assigned to the Live or DVD interventions, the elapsed time between 
completing the intervention and receiving the follow-up test set (110 screening 
mammograms) ranged from 92 days to 258 days (approximately 3 to 9 months), with one 
exception: one subject assigned to the DVD group took an unusually long time to complete 
the DVD (140 days, the maximum we observed), and so once completed, had only a 28 day 
interval before receiving the follow-up test set in the mail. No participants received the 
follow-up test set prior to completing their assigned intervention.
Control group—Radiologists who were randomly assigned to the control (delayed 
intervention) group received audit feedback as described above on their performance on the 
pre-intervention and post-intervention test sets. Control subjects were sent the self-paced 
DVD after study completion and earned additional CME if they completed the self-paced 
DVD.
CME Credits—All participants received up to 24 category 1 CME credits through the 
University of Vermont for completing the three components: pre-intervention test set, 
intervention (or delayed intervention), and post-intervention test set.
Statistical Analysis
We calculated the frequency of responses to the pre-intervention survey within each 
randomized group. For each participant, we calculated unadjusted performance measures on 
the pre-intervention and post-intervention test sets, and the corresponding pre-test to post-
test change. We generated kernel density smoothed distributional plots of changes in 
performance measures by group (23).
Performance measures of sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) were calculated relative to two outcomes: expert recall and 
cancer status. Cancer cases were defined as a diagnosis of ductal carcinoma in situ or 
invasive cancer within 12 months of the screening examination. Non-cancer cases were 
defined as cancer free at least 24 months following the screen. Expert recall included true 
positives and false-positive recalls that the experts deemed necessary to rule out cancer (6).
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Sensitivity and PPV were calculated at the lesion level. We defined lesion-level sensitivity 
as the proportion of expert recalls or cancer cases that were recalled in the correct breast and 
with correct identification of the lesion location (i.e., the participant clicked a location on the 
correct breast within the lesion region defined by the experts). Specificity was defined as the 
proportion of non-cancer cases (or expert non-recalls) not recalled by the participant.
To account for different prevalence of expert recall and cancer among the four pre-
intervention test sets, we calculated recalibrated PPV and NPV values based on each 
participant’s observed sensitivity and specificity and a common prevalence value across all 
test sets, using formulas that express PPV and NPV as functions of sensitivity, specificity, 
and prevalence (24). Prevalence was set to values that matched the post-intervention test set: 
29/110 cases for expert recall and 15/110 for analyses relative to cancer.
To compare the effect of intervention assignment on change in pre-intervention and post-
intervention performance, we fit hierarchical logistic regression models. Post-test 
improvement was evaluated using an adjusted odds ratio (OR) comparing post-intervention 
to pre-intervention performance in the two intervention arms relative to the control group. 
Models included normally distributed random effects for radiologists and cases to 
accommodate correlation among examinations interpreted by the same radiologist, and 
among cases interpreted by different radiologists. Models were adjusted for pre-intervention 
test set number, and PPV and NPV models were additionally adjusted for the prevalence of 
expert recall or cancer in that test set.
Tests of statistical significance were two-sided with an alpha level of 0.05. All analyses 
were conducted using R version 2.15.0 (25,26) and SAS 9.2 software (SAS Institute Inc., 
Cary, NC, USA).
Results
Of 119 subjects who participated in the intervention and control groups, 102 (85.7%) 
completed the post-intervention test set (Figure 1). Among those who completed the all the 
components approximately 38% had read mammograms for 10 years or fewer, and 86% 
described their ability to perceive and determine the importance of mammographic findings 
as average or above average (Table 1). More than 80% of participants read digital screening 
mammograms in clinical practice. Twenty-three radiologists assigned to the DVD 
intervention also completed at least one extra case while 12 completed all 21 extra cases 
(data not shown).
Lesion-level sensitivity relative to expert recall increased by an average of more than 10% in 
the live- and DVD-intervention groups and 7% in the control group (Table 2). Average 
specificity decreased relative to both expert recall and cancer in the live-intervention group, 
while average specificity increased in both the DVD and control groups. Average increases 
in recalibrated PPV were higher in the DVD and control groups than in the live-intervention 
group for both outcomes. Recalibrated NPV increased on average for the live-intervention 
and control groups, but showed a small average decrease in the DVD group relative to both 
expert recall and cancer.
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Improvements in sensitivity were evident for all three groups relative to expert recall (Figure 
3 panel a), but not relative to cancer status (panel c). No obvious differences appeared in the 
distribution of the changes in specificity relative to expert recall or cancer status (panels b 
and d).
Sensitivity relative to expert recall improved significantly after the DVD intervention 
according to the adjusted models (Table 3). The odds of recalling an expert-recalled case at 
the lesion level increased 1.34 times more in the DVD group (95% confidence interval [CI]: 
1.00, 1.81) compared to the corresponding increase in the control group (P=0.05), after 
adjustment for performance on the pre-intervention test set. Improvement in sensitivity in 
the live-intervention group did not differ from the control group relative to expert recall or 
cancer status. Specificity in the live-intervention group was significantly lower than in the 
control group (OR relative to expert recall = 0.80; 95% CI: 0.64, 1.00; P=0.048; OR relative 
to cancer status 0.79; 95% CI: 0.65, 0.95; P=0.015), after adjusting for baseline 
performance. The odds of expert recall given recall by participants (PPV) in the DVD group 
nearly doubled (OR=1.94; 95% CI: 1.24, 3.05) compared to the control group l(P=0.004), 
and improved by a factor of 1.81 (95% CI: 1.01, 3.23) relative to cancer status (P=0.045). 
No significant differences were observed in the changes in recalibrated NPV across the 
groups.
Finally, we determined the proportion of participants who improved by any amount for 
sensitivity, specificity, recalibrated PPV, and recalibrated NPV, along with adjusted 
improvement ORs (Table 4). After adjustment for pre-intervention test set assignment, there 
were no significant differences in the odds of improving between the live- or DVD-
intervention groups and the control group. Results were, however, consistent with the live-
intervention participants improving more frequently in sensitivity and recalibrated NPV 
relative to both outcomes, and with the control group improving most in re-calibrated PPV 
for both outcomes.
Discussion
We tested the effects of two case-based educational interventions designed to improve 
interpretive screening mammography performance. After adjustment for pre-intervention 
test set performance, the improvement in sensitivity relative to expert recall, and PPV 
relative to both expert recall and cancer were significantly higher for the DVD-intervention 
participants than for control-group participants, with no significant change in specificity. 
Thus, our study showed a positive effect on interpretive performance.
The interpretive performance of mammography varies considerably among radiologists. 
Although differences in patient populations could be partially responsible, most variability 
probably is related to interpreting physician skills. Roughly 62% of all U.S. radiologists 
interpret mammography as part of their workload, but only 10.5% consider themselves 
breast imaging specialists (27). In fact, breast imaging specialists interpret only 30% of 
mammograms in the U.S. (27). This underscores the importance of methods that improve 
the skills of general radiologists who interpret screening mammograms.
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Our report is only the second published study to use a randomized controlled design for 
interventions to improve mammography interpretive performance (28). Although only 102 
radiologists completed our study, it is the largest to date designed to measure improved 
mammography performance. Carney et al.(28) tested a 1.5-hour Internet-based CME 
designed to decrease recall rate. Participation was very low and no differences were found 
between the control and intervention group as measured by pre- and post-clinical recall rate 
(28).
Our findings differ from several other studies that were designed to improve mammography 
interpretation but used study designs that were less rigorous than a randomized controlled 
trial. Linver and colleagues (12) found that attendance at an extensive three- to four-day 
instructor-led educational program in breast imaging resulted in significant improvement in 
sensitivity but no change in PPV. Their intensive intervention used a pre-intervention and 
post-intervention clinical audit to measure change but included only 12 radiologists from a 
single practice with no control group. In another study conducted by Berg et al. (11), a one-
day CME course increased cancer detection among 21 radiologists but did not decrease the 
false positive rate. Berg et al. used only a single test set, which contained all cases with 
abnormal findings. Testing was administered immediately before and after the teaching 
intervention, and again at 2 to 3 months for a small subset of participants. The Linver study 
was published in 1992, when mammography CME courses were new, so unlike our study 
and Berg et al., participants had little or no exposure to previous mammography CME (12). 
Advantages of our study were the use of different test sets for evaluating pre-intervention 
and post-intervention performance, with interpretation 3–6 months before and after the 
intervention. Unlike many previous studies, we included normal mammograms to more 
closely resemble clinical practice.
Three studies used audit feedback to improve mammography interpretation (10,14-16,29) 
and found that feedback accompanied with extensive clinical review improves 
mammography interpretation. However, none of the audit feedback interventions were 
rigorously tested and in general, this method is very resource intensive.
The strengths of our study include that we tested two interventions, one that used a 
convenient DVD that allowed participants to proceed at their own pace, and another that 
used a live, expert-led intervention in which radiologists had the opportunity for more 
personalized interaction. We found that the DVD, which is a relatively inexpensive, easy-to-
disseminate method for delivering CME, was effective in improving mammography 
interpretation. Another strength of our study is that our participants were a large, diverse 
group of community radiologists from across the country. In addition, the cases used in our 
test sets and intervention were randomly selected from clinical practice to represent the 
diversity of real-world practice.
We focused our results on the lesion level, because detection of the lesion itself is most 
clinically relevant for improvements in mammography performance. When a woman is 
recalled for an abnormal finding on mammography, the additional imaging (e.g., diagnostic 
magnification views and/or ultrasound) focuses first on the region of interest (although the 
extent of disease is addressed during the diagnostic evaluation). Therefore, it is important to 
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detect and identify the correct lesion location. The size of the areas we accepted for correct 
recall was generous, but specific. Improving or changing the exact location of the 
radiologist’s click would not change the results. If the radiologist chose a finding within the 
broad area, they were given credit if appropriately recalled.
Although our sample was large and diverse, we had based our power calculations on 160 
radiologists participating (Supplemental table 1: power analyses); therefore, we lacked 
statistical power for detecting potentially important differences in performance. It is 
generally accepted that power calculations should not be redone after the study is completed 
(29). Instead, our focus was on reporting effect sizes with measures of precision (e.g., 95% 
confidence intervals). Despite having less statistical power than originally planned, we were 
able to show statistically significant differences, because the effect sizes from the 
interventions were higher than we anticipated in our initial sample size calculations. Had we 
had a larger sample size, we may have detected statistically significant improvements in the 
live intervention group as well. The re-randomization process may have led to a bias in the 
live intervention group, because busier radiologists may have been more likely to have 
legitimate reasons for being unable to participate. However, the DVD vs. control group 
comparison should not be biased, because radiologists who were unable to participate in the 
live intervention were randomly reassigned to one of these two groups. Our analyses used an 
intervention exposure approach instead of an intent-to-treat (ITT) approach. As a sensitivity 
analysis we conducted the ITT analysis and found the results to be in a similar direction 
(Supplemental Table 2).
More radiologists in the DVD and control groups did not complete all components of the 
study compared with the live intervention. It is very challenging to recruit and retain busy 
physicians to fully complete studies, particularly a study like this that required up to 24 
hours over a two year time period. Radiologists who made a commitment to come to our live 
intervention had to get release time for the specific day and in some instances advanced 
airplane reservations. We can only surmise that the draw of an intervention taught by 
recognized experts in the field plus having freed up time in their schedule made it more 
likely that the radiologists would attend the live intervention. Those in the control and the 
DVD groups did not necessarily get release time to complete the study and therefore had to 
fit it into a busy schedule making it more difficult to complete.
We used digitized analogue films, as does the Mammography Case Review educational sets 
of the American College of Radiology (ACR) (22) and PERFORMS(15), rather than digital 
images. Thus, the film quality was inferior to digital images and original film mammograms. 
The available data when the study began showed that only about 25% of BCSC radiologists 
were interpreting digital mammograms. This information influenced our decision to use 
digitized films, although by the time the interventions were implemented more than 80% of 
participants were reading digital mammograms in screening practice. For future 
interventions, we recommend digitally acquired images since they are readily accessible and 
most closely approximate current imaging quality and conditions.
Improvement in performance was seen even in the control group. There are at least three 
potential explanations. First, all groups, including the control group, received an outcome 
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audit feedback of the results of the pre-intervention test set (described on page 10). Second, 
the control group gained experience with reading the digitized films and operating the 
software from the pre-intervention test set. Third, there were four pre-intervention tests of 
varying difficulty and only one post-intervention test set of average difficulty such that some 
of the controls may have improved if they took the difficult pre-intervention test set. For 
these reasons, we adjusted for test set and case-difficulty in the statistical analysis and we 
compared changes in the intervention groups relative to the control group, which would 
remove these factors as driving our results.
In conclusion, continuing to develop and test methods to effectively improve interpretive 
performance is important because over 130 million women are screened with mammography 
in the U.S. every 1–2 years (3) and breast cancer remains a leading cause of cancer death. 
Results from our randomized controlled trial suggest that interpretive performance can be 
improved by educational interventions based on actual clinical cases with findings that are 
frequently misinterpreted. These findings and the improvements in interpretive performance 
observed by previous investigators suggest that direct interventions focused on improving 
the accuracy of mammography interpretation should be the highest priority for meeting 
CME requirements under MQSA. We plan to extend our results by measuring whether 
clinical recall rates changed after the interventions. We will need to wait several years to 
calculate clinical sensitivity and specificity using true cancer status because of a lag time in 
data from cancer registries. CME is increasingly being offered through the Internet, 
providing easy access to educational opportunities and expanding the dissemination 
possibilities for CME interventions such as those described in this study (30).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Flow chart of study participants
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Figure 2. Example test set case with teaching points
(a) Access to multiple views of cases; (b) question about breast density; (c) Case score and 
teaching point; (d) Additional imaging and teaching point.
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Figure 3. Graphs of test set performance measures pre- and post-intervention by intervention 
group and relative to expert recall and cancer status
Increases in sensitivity or specificity are indicated by a shift to the right. Solid line, live 
intervention; dashed line, DVD intervention; dotted line, control.
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Table 1
Radiologist characteristics overall and by random intervention assignment













Test Set, n (%)
  1 (15 cancers, lower difficulty) 25 (24.8%) 5 (20.0%) 10 (27.8%) 10 (25%)
  2 (15 cancers, higher difficulty) 30 (29.7%) 7 (28.0%) 10 (27.8%) 13 (32.5%)
  3 (30 cancers, lower difficulty) 25 (24.8%) 7 (28.0%) 10 (27.8%) 8 (20%)
  4 (30 cancers, higher difficulty) 21 (20.8%) 6 (24.0%) 6 (16.7%) 9 (22.5%)
Years interpreting mammograms, n (%)
  1-5 years 22 (21.8%) 6 (24.0%) 9 (25.0%) 7 (17.5%)
  6-10 years 17 (16.8%) 6 (24.0%) 7 (19.4%) 4 (10.0%)
  11-20 years 44 (43.6%) 8 (32.0%) 18 (50.0%) 18 (45.0%)
  21-30 years 14 (13.9%) 4 (16.0%) 0 (0.0%) 10 (25.0%)
  31 years or more 4 (4.0%) 1 (4.0%) 2 (5.6%) 1 (2.5%)
Self-rated ability to perceive & determine importance of
mammographic findings, n (%)
  Not sure 2 (2.0%) 0 (0.0%) 1 (2.8%) 1 (2.5%)
  Below Average 2 (2.0%) 1 (4.0%) 1 (2.8%) 0 (0.0%)
  Average 47 (46.5%) 11 (44.0%) 17 (47.2%) 19 (47.5%)
  Above Average 40 (39.6%) 11 (44.0%) 14 (38.9%) 15 (37.5%)
  Expert 10 (9.9%) 2 (8.0%) 3 (8.3%) 5 (12.5%)
Number of mammography examinations read per week, n (%)
  Up to 10 6 (5.9%) 2 (8.0%) 2 (5.6%) 2 (5.0%)
  11-49 20 (19.8%) 9 (36.0%) 5 (13.9%) 6 (15.0%)
  50-99 34 (33.7%) 6 (24.0%) 14 (38.9%) 14 (35.0%)
  100-199 26 (25.7%) 5 (20.0%) 11 (30.6%) 10 (25.0%)
  200 or more 15 (14.9%) 3 (12.0%) 4 (11.1%) 8 (20.0%)
Category 1 CME hours in mammography received in the past
three years (not including this program), n (%)
  none 4 (4.0%) 1 (4.0%) 3 (8.3%) 0 (0.0%)
  1-10 7 (6.9%) 2 (8.0%) 2 (5.6%) 3 (7.5%)
  11-15 18 (17.8%) 4 (16.0%) 6 (16.7%) 8 (20.0%)
  16-30 34 (33.7%) 10 (40.0%) 11 (30.6%) 13 (32.5%)
  31 or more 38 (37.6%) 8 (32.0%) 14 (38.9%) 16 (40%)
Specialization in radiology, n (%)
  Generalist (with no specialization) 21 (20.8%) 7 (28.0%) 5 (13.9%) 9 (22.5%)
  Primarily generalist (with some specialization) 45 (44.6%) 11 (44.0%) 17 (47.2%) 17 (42.5%)
  Primarily Specialist (with some general work) 27 (26.7%) 6 (24.0%) 10 (27.8%) 11 (27.5%)
  Breast Specialist (no general work) 8 (7.9%) 1 (4.0%) 4 (11.1%) 3 (7.5%)
Main practice type at time of survey, n (%)
  Community practice radiology group 56 (55.4%) 17 (68.0%) 19 (52.8%) 20 (50.0%)
  Academic radiology group 15 (14.9%) 1 (4.0%) 7 (19.4%) 7 (17.5%)
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  Radiologist in a multispecialty group 19 (18.8%) 3 (12.0%) 9 (25%) 7 (17.5%)
  Solo radiology practice 5 (5.0%) 1 (4.0%) 1 (2.8%) 3 (7.5%)
  Locum tenens 5 (5.0%) 2 (8.0%) 0 (0.0%) 3 (7.5%)
  Other 1 (1.0%) 1 (4.0%) 0 (0.0%) 0 (0.0%)
Interpreted digital screening exams at time of survey, n (%) 81 (80.2%) 22 (88%) 29 (80.6%) 30 (75%)
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Table 2
Summary of performance measures pre and post intervention, by intervention group relative to two reference 
outcomes

















  pre-intervention 51.3 (11.2) 52.3 (10.9) 54.4 (11.0) 62.0 (15.0) 66.1 (13.2) 65.5 (13.9)
  post-intervention 61.2 (9.9) 63.1 (9.8) 61.4 (11.2) 66.1 (14.6) 69.8 (14.9) 65.8 (15.9)
  change 10.0 (12.8) 10.9 (10.7) 7.0 (13.5) 4.1 (15.5) 3.7 (16.7) 0.3 (19.2)
Specificity, mean (sd)
  pre-intervention 77.9 (12.1) 74.8 (13.9) 73.1 (11.0) 69.3 (12.0) 65.8 (13.8) 64.1 (10.2)
  post-intervention 76.8 (9.5) 75.0 (14.8) 74.9 (12.6) 69.2 (9.0) 67.8 (14.0) 67.5 (12.1)




  pre-intervention 48.5 (11.2) 46.2 (12.1) 44.4 (12.5) 25.6 (6.2) 25.3 (7.7) 23.4 (6.4)
  post-intervention 50.7 (11.2) 51.5 (13.3) 49.4 (10.7) 26.2 (6.0) 27.5 (8.3) 25.4 (6.7)




  pre-intervention 88.3 (4.9) 90.1 (4.3) 89.0 (5.1) 94.4 (2.5) 95.3 (2.1) 94.8 (2.5)
  post-intervention 89.5 (6.0) 90.0 (5.0) 89.7 (5.4) 95.0 (3.0) 95.3 (2.5) 95.1 (2.7)
  change 1.2 (5.6) −0.2 (5.1) 0.7 (6.0) 0.6 (2.8) −0.1 (2.6) 0.4 (3.0)
Pre- and post-intervention performance measures have been rounded to the nearest tenth. Differences were computed at the subject level, with 
means and standard deviations calculated prior to rounding, resulting in apparent offsets of ±0.1 relative to the pre- and post-intervention values in 
some change values shown.
a
Recalibrated PPV and NPV are calculated using the observed subject-specific estimates of sensitivity and specificity, at the appropriate level of 
analysis, and assume a cancer prevalence of (15/110) and an expert recall prevalence of (29/110), both of which correspond to the prevalence 
values present in the post-intervention test set.
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Table 3
Comparison of the effects of intervention on various performance measures relative to two reference outcomes
Relative to Expert Recall Relative to Cancer
Adjusted OR
a p Adjusted OR
a p
Sensitivity
  Live vs. Control 1.24 (0.90, 1.72) 0.190 1.22 (0.78, 1.90) 0.384
  DVD vs. Control 1.34 (1.00, 1.81) 0.050 1.28 (0.85, 1.92) 0.237
Specificity
  Live vs. Control 0.80 (0.64, 1.00) 0.048 0.79 (0.65, 0.95) 0.015
  DVD vs. Control 0.90 (0.74, 1.10) 0.299 0.92 (0.77, 1.09) 0.343
PPV
  Live vs. Control 1.13 (0.69, 1.86) 0.631 1.11 (0.59, 2.09) 0.743
  DVD vs. Control 1.94 (1.24, 3.05) 0.004 1.81 (1.01, 3.23) 0.045
NPV
  Live vs. Control 1.08 (0.84, 1.39) 0.547 1.06 (0.74, 1.51) 0.752
  DVD vs. Control 0.96 (0.77, 1.21) 0.760 0.94 (0.67, 1.30) 0.694
a
Statistics shown here are performance measure odds ratios associated with intervention, adjusted for performance on the pre-intervention test sets. 
In the case of sensitivity, for example, the odds of participant recall given expert recall increased from pre-intervention to post-intervention in the 
Live group 1.24 (95% CI: 0.90, 1.72) times more than the corresponding increase in the Control group; this comparison was not statistically 
significant however, as the confidence interval included 1 (p=0.190). All models were adjusted for pre-intervention test set, and PPV and NPV 
models were additionally adjusted for the prevalence of cancer or expert recall.
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Table 4
Number of participants showing improvement from pre- to post-intervention by intervention group, and 
adjusted improvement odds ratios
















Relative to Expert Recall
  Sensitivity 21 (84%) 29 (81%) 27 (68%) 2.6 (0.7, 9.5) 2.0 (0.7, 9.5)
  Specificity 13 (52%) 19 (51%) 23 (58%) 0.8 (0.3, 2.3) 0.8 (0.3, 2.3)
  Re-calibrated PPV
b 16 (64%) 23 (64%) 28 (70%) 0.7 (0.3, 2.2) 0.7 (0.3, 2.2)
  Re-calibrated NPV
b 14 (56%) 16 (43%) 18 (45%) 1.6 (0.6, 4.5) 1.0 (0.4, 4.5)
Relative to Cancer
  Sensitivity 15 (60%) 18 (50%) 16 (40%) 2.3 (0.8, 6.8) 1.7 (0.6, 6.8)
  Specificity 14 (56%) 20 (54%) 25 (62%) 0.8 (0.3, 2.2) 0.7 (0.3, 2.2)
  Re-calibrated PPV
b 16 (64%) 23 (64%) 26 (65%) 0.9 (0.3, 2.6) 1.0 (0.4, 2.6)
  Re-calibrated NPV
b 14 (56%) 16 (43%) 18 (45%) 1.6 (0.6, 4.5) 1.0 (0.4, 4.5)
a
Odds ratio estimates are from logistic models of a binary indicator of improvement from pre- to post-intervention, regressed on intervention 
group, and are adjusted for pre-intervention test set assignment.
b
Recalibrated PPV and NPV are calculated using the observed subject-specific estimates of sensitivity and specificity, and assume a cancer 
prevalence of (15/110) and an expert recall prevalence of (29/110), both of which correspond to the prevalence values present in the post-
intervention test set.
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